Phathom Pharmaceuticals Inc (PHAT)

Aug 09, 2025

Phathom projects $165M–$175M 2025 revenue as GI sales focus accelerates VOQUEZNA growth - MSN

Aug 09, 2025

Aug 09, 2025

Phathom Pharmaceuticals Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance

Aug 09, 2025

Aug 09, 2025

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 09, 2025

Aug 09, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 09, 2025

Aug 08, 2025

A Quick Look at Today's Ratings for Phathom Pharmaceuticals(PHAT.US), With a Forecast Between $17 to $28 - 富途牛牛

Aug 08, 2025

Aug 08, 2025

Phathom 2025 Q2 Earnings Net Loss Narrows 17.1% - AInvest

Aug 08, 2025

Aug 08, 2025

Phathom Pharmaceuticals Inc (PHAT) Q2 2025 Earnings Call Highlig - GuruFocus

Aug 08, 2025

Aug 08, 2025

Phathom Pharmaceuticals Reports Strong Q2 Growth - TipRanks

Aug 08, 2025

Aug 07, 2025

Phathom Pharmaceuticals Q2 2025: Unpacking Contradictions in Growth Strategies and Market Focus - AInvest

Aug 07, 2025

Aug 07, 2025

Phathom Pharmaceuticals Stock (PHAT) Opinions on Q2 2025 Earnings Report - Quiver Quantitative

Aug 07, 2025

Aug 07, 2025

Phathom Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Phathom Pharmaceuticals Q2 2025 slides: VOQUEZNA growth drives revenue beat - Investing.com Canada

Aug 07, 2025

Aug 07, 2025

Earnings call transcript: Phathom Pharmaceuticals Q2 2025 beats revenue expectations - Investing.com Australia

Aug 07, 2025

Aug 07, 2025

Phathom Pharmaceuticals (PHAT) Q2 Earnings: Revenue Surpasses Es - GuruFocus

Aug 07, 2025

Aug 07, 2025

Phathom Pharmaceuticals Q2 2025 Financial Results - TradingView

Aug 07, 2025

Aug 07, 2025

Phathom Pharmaceuticals' Strategic Restructuring and Market Position: A Pathway to Long-Term Value Creation in a Capital-Constrained Biopharma Landscape - AInvest

Aug 07, 2025

Aug 07, 2025

Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewswire

Aug 07, 2025

Aug 04, 2025

Published on: 2025-08-04 08:41:19 - metal.it

Aug 04, 2025

Aug 03, 2025

Does Phathom Pharmaceuticals Inc. stock perform well during market downturnsOutstanding trading profits - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Phathom Pharmaceuticals Inc. a growth stock or a value stockBuild a portfolio that withstands market volatility - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is it the right time to buy Phathom Pharmaceuticals Inc. stockDiscover undervalued stocks before they soar - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Phathom Pharmaceuticals Inc. generate profit in a changing economySkyrocketing investment returns - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Phathom Pharmaceuticals Inc. stock in 2025Achieve impressive returns with smart timing - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Phathom Pharmaceuticals Inc. as a “Buy”Unlock exclusive stock market insights - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Phathom Pharmaceuticals Inc. stock expected to show significant growthInvest smarter with data-backed trading alerts - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What is the dividend policy of Phathom Pharmaceuticals Inc. stockBuild wealth steadily with proven strategies - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What catalysts could drive Phathom Pharmaceuticals Inc. stock higher in 2025Free Stock Market Real-Time Monitoring - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Several Insiders Invested In Phathom Pharmaceuticals Flagging Positive News - 富途牛牛

Aug 01, 2025

Aug 01, 2025

Published on: 2025-08-01 16:17:13 - metal.it

Aug 01, 2025

Jul 28, 2025

Elliott Wave Theory Predicts Pullback in Phathom Pharmaceuticals Inc.Low Risk Picks for Daily Trading Released - metal.it

Jul 28, 2025

Jul 28, 2025

Phathom Pharmaceuticals to Report Second Quarter 2025 - GlobeNewswire

Jul 28, 2025

Jul 28, 2025

What are the latest earnings results for Phathom Pharmaceuticals Inc.High-octane financial growth - Jammu Links News

Jul 28, 2025

Jul 28, 2025

What are the technical indicators suggesting about Phathom Pharmaceuticals Inc.Robust investment performance - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Phathom Pharmaceuticals To Report Second Quarter 2025 Financial Results And Provide Business Update On Thursday, August 7, 2025 - TradingView

Jul 28, 2025

Jul 28, 2025

Phathom Pharmaceuticals to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative

Jul 28, 2025

Jul 28, 2025

Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025 - The Manila Times

Jul 28, 2025

Jul 28, 2025

Phathom Pharmaceuticals to Reveal Q2 2025 Performance: Key Updates on VOQUEZNA Sales Expected - Stock Titan

Jul 28, 2025

Jul 28, 2025

What is Phathom Pharmaceuticals Inc. company’s growth strategyInvest with confidence backed by data - Jammu Links News

Jul 28, 2025

Jul 27, 2025

What makes Phathom Pharmaceuticals Inc. stock price move sharplyFree Real-Time Market Predictions - metal.it

Jul 27, 2025

Jul 27, 2025

What is the risk reward ratio of investing in Phathom Pharmaceuticals Inc. stockMaximize profits with strategic stock selection - jammulinksnews.com

Jul 27, 2025

Jul 25, 2025

When Will Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Turn A Profit? - 富途牛牛

Jul 25, 2025

Jul 23, 2025

What analysts say about Phathom Pharmaceuticals Inc. stockFree Capital Allocation Plans - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

Is Phathom Pharmaceuticals Inc. a good long term investmentFree Daily Trading Room Entry - Jammu Links News

Jul 23, 2025

Jul 23, 2025

Phathom Pharmaceuticals Inc. Stock Analysis and ForecastConsistent triple returns - Jammu Links News

Jul 23, 2025